BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37824413)

  • 21. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraduodenal pancreatitis: benign and malignant mimics at MRI.
    Mittal PK; Harri P; Nandwana S; Moreno CC; Muraki T; Adsay V; Cox K; Pehlivanoglu B; Alexander LF; Chatterjee A; Miller FH
    Abdom Radiol (NY); 2017 Nov; 42(11):2652-2674. PubMed ID: 28660333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
    Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
    Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
    Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study.
    Hoogenboom SA; Engels MML; Chuprin AV; van Hooft JE; LeGout JD; Wallace MB; Bolan CW
    Abdom Radiol (NY); 2022 Dec; 47(12):4160-4172. PubMed ID: 36127473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key endoscopic ultrasound features of pancreatic ductal adenocarcinoma smaller than 20 mm.
    Aso A; Ihara E; Osoegawa T; Nakamura K; Itaba S; Igarashi H; Ito T; Aishima S; Oda Y; Tanaka M; Takayanagi R
    Scand J Gastroenterol; 2014 Mar; 49(3):332-8. PubMed ID: 24417737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma.
    Kang JD; Clarke SE; Costa AF
    Eur Radiol; 2021 Apr; 31(4):2422-2432. PubMed ID: 32997176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreas Ductal Adenocarcinoma and its Mimics: Review of Cross-sectional Imaging Findings for Differential Diagnosis.
    Kim SS; Choi GC; Jou SS
    J Belg Soc Radiol; 2018 Oct; 102(1):71. PubMed ID: 30386851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
    Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
    Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant Pancreatic Ductal Adenocarcinoma and Type 1 Autoimmune Pancreatitis: A Potential Issue in the Diagnosis of Carcinoma by Endoscopic Ultrasound-guided Fine-needle Biopsy.
    Kachi K; Naitoh I; Ban T; Hayashi K; Yoshida M; Hori Y; Natsume M; Kato A; Kito Y; Saito K; Matsuo Y; Kato H; Naiki-Ito A; Takahashi S; Notohara K; Kataoka H
    Intern Med; 2023 Feb; 62(4):545-551. PubMed ID: 35831103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, corona, and attraction signs.
    Beker K; Lee KS; Tsai LL; Hegazi T; Garces-Descovich A; Brook A; Mortele KJ
    Abdom Radiol (NY); 2019 Dec; 44(12):4048-4056. PubMed ID: 31352623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.
    Haj-Mirzaian A; Kawamoto S; Zaheer A; Hruban RH; Fishman EK; Chu LC
    Abdom Radiol (NY); 2020 Feb; 45(2):457-478. PubMed ID: 31897686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging classification of pancreatic ductal adenocarcinoma with histological large duct pattern.
    Lee JE; Lee S; Park HJ; Hwang JA; Choi SY; Lee J
    Eur Radiol; 2024 May; ():. PubMed ID: 38806802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomics model of dual-time 2-[
    Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
    Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.